JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2015, Vol. 29 ›› Issue (3): 65-71.doi: 10.6040/j.issn.1673-3770.0.2014.293

Previous Articles     Next Articles

Erythropoietin inhibits Müller cell apoptosis induced by oxidative damage

CHEN Chunli1, SONG Zongming2, JIA Xinguo3, ZHOU Zhonglou2, WANG Zhaoyang3   

  1. 1. Shengli Oilfield Central Hospital, Dongying 257034, Shandong, China;
    2. The Eye Hospital of WMU, Wenzhou 325027, Zhejiang, China; 3. Xinhua College of Clinical Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
  • Received:2014-09-01 Revised:2015-04-04 Published:2015-06-16

Abstract: Objective To demonstrate whether EPO can inhibit Müller cell apoptosis induced by oxidative damage and to investigate the molecular mechanism. Methods The proliferation effect of EPO on cultured human Müller cell-MIO-M1 was determined by BrdU marking and MTT assay both under normal condition and exposed to H2O2 or GO with different concentration (0 U/mL, 0.01 U/mL, 0.1 U/mL, 1 U/mL, 10 U/mL, 30 U/mL and 100 U/mL) at 24 h, 48 h and 72 h after exposure. The Müller cell proliferation changes after the use of PI3K/PDK1/PKB(Akt) signal pathway blocker-LY294002 was surveyed by MTT assay. The Müller cell function on EPO expression and secretion was observed by ELISA. The EPO effect on ERK1/2 and Akt signal pathway was detected under different cultured condition in vitro by Western-blotting. Results EPO had no effect on Müller cell proliferation under normal culture condition. The 80% damaged Müller cell caused by 0.4 mmol/L H2O2 can secrete 1.42 times EPO as that under normal culture condition. Under oxidative damage condition, 0.08 mmol/L H2O2 or 8 U/L GO could cause half of Müller cells to be dead and activate Akt signal pathway. While adding EPO 2 h earlier, 30 U/mL of EPO can reduce the oxidative damage to the minimum. The protection effect of Akt signal pathway could be reduced by its blocker LY294002 spontaneously. Conclusion EPO has no proliferation and migration effects on Müller cells cultured in vitro. Under normal culture condition, Müller cells did not express and secrete EPO. While under oxidative damage, Müller cells can secret EPO which can protect Müller cells by Akt signal pathway.

Key words: ller cells, Age-related macular degeneration, Mü, Erythropoietin, Proliferation

CLC Number: 

  • R774.1
[1] Bird A C. The Bowman lecture. Towards an understanding of age-related macular disease[J]. Eye, 2003, 17(4):457-466.
[2] Harvey P T. Common eye diseases of elderly people: identifying and treating causes of vision loss[J]. Gerontology, 2003, 49(1):1-11.
[3] Mansoor S, Gupta N, Luczy-Bachman G, et al. Protective effects of memantine and epicatechin on catechol-induced toxicity on Müller cells in vitro[J]. Toxicology, 2010, 271(1):107-114.
[4] Sullivan R, Penfold P, Pow D V. Neuronal migration and glial remodeling in degenerating retinas of aged rats and in nonneovascular AMD[J]. Invest Ophthalmol Vis Sci, 2003, 44(2):856-865.
[5] Ambati J, Ambati B K, Yoo S H, et al. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies[J]. Surv Ophthalmol, 2003, 48(3):257-293.
[6] Nowak J Z. Age-related macular degeneration (AMD): pathogenesis and therapy[J]. Pharmacol Re, 2006, 58(3):353-363.
[7] Kaur C, Foulds W S, Ling E A. Blood-retinal barrier in hypoxicischaemic ditions: basic concepts, clinical features and management[J]. Prog Retin Eye Res, 2008, 27(6): 622-647.
[8] Wang Z Y, Shen L J, Tu L, et al. Erythropoietin protects retinal pigment epithelial cells from oxidative damage[J]. Free Radic Biol Med, 2009, 46(8):1032-1041.
[9] Ye M, Hu D, Tu L, et al. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor—induced migration of uveal melanoma cells[J]. Invest Ophthalmol Vis Sci, 2008, 49(2):497-504.
[10] Beatty S, Koh H, Phil M, et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration[J]. Surv Ophthalmol, 2000, 45(2):115-134.
[11] Godley B F, Jin G F, Guo Y S, et al. Bcl-2 overexpression increases survival in human retinal pigment epithelial cells exposed to H2O2[J]. Exp Eye Res, 2002, 74(6):663-669.
[12] Kaur C, Foulds W S, Ling E A. Blood-retinal barrier in hypoxicischaemic conditions: basic concepts, clinical features and management[J]. Prog Retin Eye Res, 2008, 27(6): 622-647.
[13] Barbouti A, Doulias P T, Nousis L, et al. DNA damage and apoptosis in hydrogen peroxide-exposed Jurkat cells: bolus addition versus continuous generation of H2O2[J]. Free Radic Biol Med, 2002, 33(5): 691-702.
[14] Rollet-Labelle E, Grange M J, Elbim C, et al. Hydroxyl radical as a potential intracellular mediator of polymorphonuclear neutrophil apoptosis[J]. Free Radic Biol Med, 1998, 24(4):563-572.
[15] Halliwell B, Clement M V, Long L H. Hydrogen peroxide in the human body[J].FEBS Lett, 2000, 486(1):10-13.
[16] Cai J, Nelson K C, Wu M, et al. Oxidative damage and protection of the RPE[J]. Prog Ret Eye Res, 2000, 19(2):205-221.
[17] Fu Q L, Wu W, Wang H, et al. Up-regulated endogenous erythropoietin/erythropoietin receptor system and exogenous erythropoietin rescue retinal ganglion cells after chronic ocular hypertension[J]. Cell Mol Neurobiol, 2008, 28(2):317-329.
[18] Chong Z Z, Kang J Q, Maiese K. Erythropoietin is a novel vascular protectant through activation of AKT1 and mitochondrial modulation of cysteine proteases[J]. Circulation, 2002, 106(23):2973-2979.
[19] Katavetin P, Tungsanga K, Eiam-Ong S, et al. Antioxidative effects oferythropoietin[J]. Kidney Int Suppl, 2007, 107(1):10-15.
[20] Digicaylioglu M, Lipton S A. Erythropoietin-mediated neuroprotection involvescross-talk between Jak2 and NF-kappaB signalling cascades[J]. Nature, 2001, 412(6847):641-647.
[21] Parsa C J, Matsumoto A, Kim J, et al. Novel protective effect of erythropoietin in the infarcted heart[J]. J Clin Invest, 2003, 112(7):999-1007.
[22] Kilic U, Kilic E, Soliz J, et al. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2[J]. FASEB J, 2005, 19(3):249-251.
[23] Zhong L, Bradley J, Schubert W, et al. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice[J]. Invest Ophthalmol Vis Sci, 2007, 48(3):1212-1218.
[24] Tsai J C, Wu L, Worgul B, et al. Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma[J]. Curr Eye Res, 2005, 30(11):1025-1031.
[25] Yamasaki M, Mishima H K, Yamashita H, et al. Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells[J]. Brain Res, 2005, 1050(1):15-26.
[26] Chong Z Z, Lin S H, Kang J Q, et al. Erythropoietin prevents early and late neuronal demise through modulation of AKT1 and induction of caspase 1, 3, and 8[J]. J Neurosci Res, 2003, 71(5):659-669.
[27] García-Ramírez M, Hernández C, Simó R. Expression of erythropoietin and its receptor in the human retina. A comparative study of diabetic and non-diabetic subjects[J]. Diabetes Care, 2008, 31(6):1189-1194.
[28] Barbouti A, Doulias P T, Nousis L, et al. DNA damage and apoptosis in hydrogen peroxide-exposed Jurkat cells: bolus addition versus continuous generation of H2O2[J]. Free Radic Biol Med, 2002, 33(5): 691-702.
[29] Zhang J, Wu Y, Jin Y, et al. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes[J]. Invest Ophthalmol Vis Sci, 2008, 49(2):732-742.
[30] Bartesaghi S, Marinovich M, Corsini E, et al. Erythropoietin: a novel neuroprotective cytokine[J]. Neurotoxicology, 2005, 26(5):923-928.
[31] Hanada M, Feng J, Hemmings B A. Structure, regulation and function of PKB/AKT-a major therapeutic target[J]. Biochim Biophys Acta, 2004, 1697(1):3-16.
[32] Cantley L C. The phosphoinositide 3-kinase pathway[J].Science, 2002, 296(5573):1655-1657.
[33] Yang P, Peairs J J, Tano R, et al. Oxidant-mediated Akt activation in human RPE cells[J]. Invest Ophthalmol Vis Sci, 2006, 47(10):4598-4606.
[34] Wang Z Y, Zhao K K, Song Z M, et al. Erythropoietin as a novel therapeutic agent for atrophic age-related macular degeneration[J]. Med Hypotheses, 2009, 72(4):448-450.
[1] LI Guobin, ZHANG Zhancheng, WANG Xinyan. Up-regulation of miR-200b may inhibit epithelial mesenchymal transition process to prevent the proliferation, migration, and invasion of human laryngeal cancer Hep-2 cells [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 53-57.
[2] ZHOU Yibo, GONG Xiaorong, YU Feng. Effects of miR-150 targeted to Nanog on proliferation and invasion of nasopharyngeal carcinoma side population cells. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(5): 79-84.
[3] JI Shuaifei, ZHANG Jie, YAN Hong. Selection of intraocular lens for patients with age-related macular degeneration. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 36-39.
[4] WANG Cui, YAN Xin, ZHAO Bojun. Combination of intravitreal ranibizumab with photodynamic therapy in the treatment of wet age-related macular degeneration. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 94-97.
[5] . Curcumin combined with resveratrol enhances their anti-tumoral effects in the head and neck carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(2): 67-72.
[6] TIAN Xu, HUO Hong, LI Wuyi, WANG Jian, YANG Dahai. Endoscopy with Müllers maneuver and airway pressure measurement method on the evaluation of the upper airway of obstructive sleep apnea hypopnea syndrome. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(5): 29-32.
[7] XU Yuanteng, CHEN Ruiqing, LIN Gongbiao, FANG Xiuling, YU Shujuan, LIANG Xiaohua, ZHANG Rong. Effect of silencing PDCD4 gene on proliferation of Hep-2 cells and the expression of β-catenin by RNA interference technique. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(5): 110-114.
[8] ZHAO Lu, XIE Guoli, WANG Yanling. Changes of ocular hemodynamics after intravitreal ranibizumab injection in patients with wet age-related macular degeneration. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(4): 101-104.
[9] WEI Xi-jian1, YIN Rui-lan2, GUO Xing3. Expression of a proliferation-inducing ligand in laryngeal squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(1): 14-16.
[10] ZHANG Ai-hui1, ZHU Ling1, ZHANG Jin-zhi1, ZHANG Wei2. Correlation between cataract phacoemulsification with intraocular lens implantation and age-related macular degeneration [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(5): 77-83.
[11] SHAO Yan1, XU Xin-rong2. Advances in study of traditional Chinese medicine on age-related macular degeneration [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(5): 91-94.
[12] LI Da-wei, DONG Pin, GAO Shang. Significance of apoptotic and proliferative indices and  P-glycoprotein expression in laryngeal squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2011, 25(4): 8-12.
[13] GAO Shang, DONG Pin, LI Da-Wei, SHEN Bin. Potential mechanism of Platelet derived growth factor-BB to  promote the proliferation and invasion of Hep2 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2011, 25(1): 20-23.
[14] LIN Xing-qiang,WANG Hui-ge,SHEN Zhi-zhong,ZHANG Yan,YE Hui-jie,YANG Dan-na . Comparison between proliferation activity and apoptosis activity of epithelial cells in nasal polyps [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(5): 430-432 .
[15] ZHANG Hui-ping,ZHANG Peng-fei,SHANGGUAN Han-jing,LAN shu-zhan . Expression of ABAD/HADH Ⅱ in laryngeal squamous cell carcinoma and vocal polyp [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(5): 444-446 .
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!